Gene: [00.0/CZP2] cataract, zonular pulverulent 2; [CAE2 ] — Gene: [00.0/ITGA8] integrin, alpha 8;

  • Gene: [00.0/CZP2] cataract, zonular pulverulent 2; [CAE2 ]
  • Gene: [00.0/DARS] aspartyl-tRNA synthetase;
  • Gene: [00.0/DASOX] D-aspartate oxidase;
  • Gene: [00.0/DCTD] dCMP deaminase;
  • Gene: [00.0/DCTN2] dynactin 2 (p50); [RBP50 ]
  • Gene: [00.0/DDT] D-dopachrome tautomerase (phenylpyruvate tautomerase II);
  • Gene: [00.0/DDX7] DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 7 (RNA helicase, 52kD);
  • Gene: [00.0/DDX8] DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 8 (RNA helicase); helicase, RNA, nuclear 4; [HLR4 HRH1 ]
  • Gene: [00.0/DDX9] DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 9 (RNA helicase A);
  • Gene: [00.0/DECR] 2,4-dienoyl-CoA reductase (NADPH); 2,4-dienoyl-Coa reductase deficiency;
  • Gene: [00.0/DFFA] DNA fragmentation factor, alpha (45kD); [DFF1 ]
  • Gene: [00.0/DFFB] DNA fragmentation factor, beta (40kD); [DFF2 ]
  • Gene: [00.0/DFNA14] deafness, autosomal dominant 14;
  • Gene: [00.0/DFNA16] deafness, autosomal dominant 16;
  • Gene: [00.0/DFNB10] deafness, autosomal recessive 10;
  • Gene: [00.0/DFNB14] deafness, autosomal recessive 14;
  • Gene: [00.0/DFNB15] deafness, autosomal recessive 15;
  • Gene: [00.0/DFNB19] deafness, autosomal recessive 19;
  • Gene: [00.0/DF] complement component D (adipsin, C3 convertase activator);
  • Gene: [00.0/DGKB] diacylglycerol kinase, beta (90kD);
  • Gene: [00.0/DGKD] diacylglycerol kinase, delta (130kD);
  • Gene: [00.0/DGKE] diacylglycerol kinase, epsilon (64kD);
  • Gene: [00.0/DHCR24] 24-dehydrocholesterol reductase;
  • Gene: [00.0/DIA2] diaphorase 2 (NADPH-dependent);
  • Gene: [00.0/DIA3] diaphorase 3 (sperm);
  • Gene: [00.0/DIH1] diaphragmatic hernia 1;
  • Gene: [00.0/DIO2] deiodinase, iodothyronine type II; thyroxine deiodinase type II (selenoprotein);
  • Gene: [00.0/DIO3] deiodinase, iodothyronine type III; thyroxine deiodinase type III (selenoprotein);
  • Gene: [00.0/DLG2] discs, large (Drosophila) homolog 2 (chapsyn-110);
  • Gene: [00.0/DLSTP] dihydrolipoamide S-succinyltransferase pseudogene (E2 component of 2-oxo-glutarate complex);
  • Gene: [00.0/DMC1H] disrupted meiotic cDNA 1 homolog;
  • Gene: [00.0/DNAH13] dynein, axonemal, heavy polypeptide 13;
  • Gene: [00.0/DNAH14] dynein, axonemal, heavy polypeptide 14;
  • Gene: [00.0/DNAH1] dynein, axonemal, heavy polypeptide 1;
  • Gene: [00.0/DNAH2] dynein, axonemal, heavy polypeptide 2;
  • Gene: [00.0/DNAH3] dynein, axonemal, heavy polypeptide 3;
  • Gene: [00.0/DNAH5] dynein, axonemal, heavy polypeptide 5;
  • Gene: [00.0/DNAH6] dynein, axonemal, heavy polypeptide 6;
  • Gene: [00.0/DNAH8] dynein, axonemal, heavy polypeptide 8;
  • Gene: [00.0/DNAH9] dynein, axonemal, heavy polypeptide 9;
  • Gene: [00.0/DNCH1] dynein, cytoplasmic, heavy polypeptide 1; [DNEC1 ]
  • Gene: [00.0/DNCH2] dynein, cytoplasmic, heavy polypeptide 2;
  • Gene: [00.0/DNCI1] dynein, cytoplasmic, intermediate polypeptide 1;
  • Gene: [00.0/DNCI2] dynein, cytoplasmic, intermediate polypeptide 2;
  • Gene: [00.0/DNCLI2] dynein, cytoplasmic, light intermediate polypeptide 2;
  • Gene: [00.0/DNM2] dynamin 2;
  • Gene: [00.0/DOCK2] dedicator of cyto-kinesis 2 (similar to a major CRK-binding protein DOCK180); [KIAA0209 ]
  • Gene: [00.0/DOCK3] dedicator of cyto-kinesis 3 (similar to a major CRK-binding protein DOCK180); [KIAA0299 ]
  • Gene: [00.0/DOK1] docking protein 1 (downstream of tyrosine kinase 1); [p62dok ]
  • Gene: [00.0/DO] Dombrock blood group;
  • Gene: [00.0/DPAGT2] dolichyl-phosphate alpha-N-acetylglucosaminyltransferase 2 (GlcNAc-1-P transferase);
  • Gene: [00.0/DPH2L2] diptheria toxin resistance protein required for diphthamide biosynthesis (Saccharomyces)-like 2;
  • Gene: [00.0/DPYSL3] dihydropyrimidinase-like 3; unc-33-like phosphoprotein (C. elegans) homolog; [DRP-3 ULIP ]
  • Gene: [00.0/DPYSL4] dihydropyrimidinase-like 4; [ULIP4 ]
  • Gene: [00.0/DPYS] dihydropyrimidinase (DHPase; hydantoinase); dihydropyrimidinuria (dihydropyrimidinase deficiency);
  • Gene: [00.0/DR4] death receptor 4; cytotoxic ligand TRAIL receptor 1; [TRAIL-R1 ]
  • Gene: [00.0/DRIL1] dead ringer (Drosophila)-like 1;
  • Gene: [00.0/DSIPI] delta sleep inducing peptide, immunoreactor; [DIP ]
  • Gene: [00.0/DTX1] deltex (Drosophila) homolog 1; [hDx-1 ]
  • Gene: [00.0/DWS] Dandy-Walker syndrome;
  • Gene: [00.0/DYT2] dystonia 2, torsion (autosomal recessive);
  • Gene: [00.0/DYT4] dystonia 4, torsion (autosomal dominant);
  • Gene: [00.0/DYX1] dyslexia (reading disability), specific, 1;
  • Gene: [00.0/E2F5] E2F transcription factor 5, p107/p130-binding; [E2F-6 ]
  • Gene: [00.0/E2F6] E2F transcription factor 6; [E2F-6 ]
  • Gene: [00.0/E3B1] eps8 SH3 domain binding protein;
  • Gene: [00.0/E4F1] E4F transcription factor 1;
  • Gene: [00.0/EBI2] Epstein-Barr virus induced gene 2; G protein-coupled receptor, lymphocyte-specific 2;
  • Gene: [00.0/EBP] phenylalkylamine Ca2+ antagonist (emopamil) binding protein;
  • Gene: [00.0/EBR4] epidermolysis bullosa 4, pseudojunctional (intraepidermal);
  • Gene: [00.0/ECM] endothelial cell multimerin;
  • Gene: [00.0/ECT] epilepsy, centrotemporal;
  • Gene: [00.0/ED4] ectodermal dysplasia 4 (Margarita Island type);
  • Gene: [00.0/EDG2] endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2; G protein-coupled receptor, endothelial differentiation gene 2; ventricular zone gene 1; [vzg-1 rec.1.3 ]
  • Gene: [00.0/EDM3] epiphyseal dysplasia, multiple 3;
  • Gene: [00.0/EDR1] early development regulator 1 (homolog of polyhomeotic 1); [HPH1 ]
  • Gene: [00.0/EDR2] early development regulator 2 (homolog of polyhomeotic 2); [HPH2 ]
  • Gene: [00.0/ED] ectodermal dysplasia, anhidrotic (hypohydrotic) 2, autosomal recessive; [ARHED EDA2 ]
  • Gene: [00.0/EEA1] early endosome antigen 1; early endosome-associated protein;
  • Gene: [00.0/EEF1A1] eukaryotic translation elongation factor 1 alpha 1; [EF1A EEF1A ]
  • Gene: [00.0/EEF1A2] eukaryotic translation elongation factor 1 alpha 2 (statin S1); [STN ]
  • Gene: [00.0/EEF1AL10] eukaryotic translation elongation factor 1 alpha-like 10;
  • Gene: [00.0/EEF1AL11] eukaryotic translation elongation factor 1 alpha-like 11;
  • Gene: [00.0/EEF1AL12] eukaryotic translation elongation factor 1 alpha-like 12;
  • Gene: [00.0/EEF1AL13] eukaryotic translation elongation factor 1 alpha-like 13;
  • Gene: [00.0/EEF1AL2] eukaryotic translation elongation factor 1 alpha-like 2;
  • Gene: [00.0/EEF1AL3] eukaryotic translation elongation factor 1 alpha-like 3;
  • Gene: [00.0/EEF1AL4] eukaryotic translation elongation factor 1 alpha-like 4;
  • Gene: [00.0/EEF1AL5] eukaryotic translation elongation factor 1 alpha-like 5;
  • Gene: [00.0/EEF1AL6] eukaryotic translation elongation factor 1 alpha-like 6;
  • Gene: [00.0/EEF1AL7] eukaryotic translation elongation factor 1 alpha-like 7;
  • Gene: [00.0/EEF1AL8] eukaryotic translation elongation factor 1 alpha-like 8;
  • Gene: [00.0/EEF1AL9] eukaryotic translation elongation factor 1 alpha-like 9;
  • Gene: [00.0/EEF1D] eukaryotic translation elongation factor 1 delta; guanine nucleotide exchange protein;
  • Gene: [00.0/EEF1G] eukaryotic translation elongation factor 1 gamma;
  • Gene: [00.0/EFNA2] ephrin-A2; eph-related receptor tyrosine kinase ligand 6; [EPLG6 ELF-1 ]
  • Gene: [00.0/EFNA5] ephrin-A5; eph-related receptor tyrosine kinase ligand 7; [EPLG7 AF1 ]
  • Gene: [00.0/EFTS] translational elongation factor Ts, mitochondrial;
  • Gene: [00.0/EGFL1] EGF-like-domain, multiple 1; [MEGF2 ]
  • Gene: [00.0/EGFL2] EGF-like-domain, multiple 2 (similar to cadherin-related tumor suppressor hFat protein); [MEGF3 ]
  • Gene: [00.0/EGFL3] EGF-like-domain, multiple 3; [MEGF6 ]
  • Gene: [00.0/EGFL4] EGF-like-domain, multiple 4; [MEGF8 ]
  • Gene: [00.0/EGFL5] EGF-like-domain, multiple 5; [MEGF9 ]
  • Gene: [00.0/EHK2] EPH homology kinase 2 (tyrosine-protein kinase receptor EHK2);
  • Gene: [00.0/EIF1] eukaryotic translation initiation factor 1;
  • Gene: [00.0/EIF2B1] eukaryotic translation initiation factor 2B, subunit 1 (alpha); [EIF2B ]
  • Gene: [00.0/EIF2B3] eukaryotic translation initiation factor 2B, subunit 3 (gamma, 58kD);
  • Gene: [00.0/EIF2B4] eukaryotic translation initiation factor 2B, subunit 4 (delta, 67kD);
  • Gene: [00.0/EIF2B5] eukaryotic translation initiation factor 2B, subunit 5 (epsilon, 82kD);
  • Gene: [00.0/EIF2S1] eukaryotic translation initiation factor 2, subunit 1 (alpha, 35kD); eukaryotic translation initiation factor 2A; [EIF2A EIF2 ]
  • Gene: [00.0/EIF2S2] eukaryotic translation initiation factor 2, subunit 2 (beta, 38kD); [EIF2 ]
  • Gene: [00.0/EIF3S1] eukaryotic translation initiation factor 3, subunit 1 (alpha, 35kD);
  • Gene: [00.0/EIF3S2] eukaryotic translation initiation factor 3, subunit 2 (beta, 36kD); eukaryotic translation initiation factor 3D (p36); TGF-beta receptor interacting protein 1; [EIF3D EIF3 ]
  • Gene: [00.0/EIF3S3] eukaryotic translation initiation factor 3, subunit 3 (gamma, 40kD);
  • Gene: [00.0/EIF3S4] eukaryotic translation initiation factor 3, subunit 4 (delta, 44kD);
  • Gene: [00.0/EIF3S5] eukaryotic translation initiation factor 3, subunit 5 (epsilon, 47kD);
  • Gene: [00.0/EIF3S7] eukaryotic translation initiation factor 3, subunit 7 (zeta, 66/67kD);
  • Gene: [00.0/EIF3S8] eukaryotic translation initiation factor 3, subunit 8 (110kD);
  • Gene: [00.0/EIF3S9] eukaryotic translation initiation factor 3, subunit 9 (eta, 116kD); eukaryotic translation initiation factor 3B (p116; human homolog of yeast Prt1 gene); [EIF3B Prt1 ]
  • Gene: [00.0/EIF4B] eukaryotic translation initiation factor 4B;
  • Gene: [00.0/EIF4] eukaryotic translation initiation factor 4;
  • Gene: [00.0/EIF5] eukaryotic translation initiation factor 5;
  • Gene: [00.0/ELAVL3] ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3; Hu antigen C; [HUC ]
  • Gene: [00.0/ELF1] E74-like factor 1 (ets domain transcription factor);
  • Gene: [00.0/ELF2] E74-like factor 2 (ets domain transcription factor);
  • Gene: [00.0/ELF4] E74-like factor 4 (ets domain transcription factor); [MEF ]
  • Gene: [00.0/ELL2] RNA polymerase II elongation factor ELL2;
  • Gene: [00.0/ELNR1] elastin receptor 1 (67kD);
  • Gene: [00.0/EMP1] epithelial membrane protein 1 (tumor-associated); [TMP B4B ]
  • Gene: [00.0/EMP2] epithelial membrane protein 2 (tumor-associated); [XMP ]
  • Gene: [00.0/EMP3] epithelial membrane protein 3 (tumor-associated); [YMP ]
  • Gene: [00.0/ENO1L1] enolase 1, (alpha)-like 1;
  • Gene: [00.0/ENPEP] glutamyl aminopeptidase (aminopeptidase A);
  • Gene: [00.0/EPAS1] endothelial PAS domain protein 1; [MOP2 ]
  • Gene: [00.0/EPHA4] ephrin receptor EphA4; protein tyrosine kinase TYRO1; human embryo kinase 8;
  • Gene: [00.0/EPHA5] ephrin receptor EphA5; EPH homology kinase 1 (tyrosine-protein kinase receptor EHK1); human embryo kinase 7;
  • Gene: [00.0/EPHA7] ephrin receptor EphA7; EPH homology kinase 3 (tyrosine-protein kinase receptor EHK3); human embryo kinase 11;
  • Gene: [00.0/EPX] eosinophil peroxidase; hereditary eosinophil peroxidase deficiency (Presentey anomaly; MIM:261500);
  • Gene: [00.0/ERCC8] excision repair cross-complementing rodent repair deficiency, complementation group 8;
  • Gene: [00.0/EREG] epiregulin (EGF-related growth regulating peptide);
  • Gene: [00.0/ERVH2] endogenous retroviral sequence, HTLV-1 related 2; [HRES2 ]
  • Gene: [00.0/ERVSSAL] endogenous retroviral sequence simian sarcoma-associated-like; simian sarcoma-associated virus 1-like; gibbon ape leukemia virus-related endogenous retroviral element 1-like; [SSAV1L ]
  • Gene: [00.0/ESR2] estrogen receptor 2;
  • Gene: [00.0/ETF1] eukaryotic translation termination factor 1; [ERF ]
  • Gene: [00.0/EYCL2] eye color 2 (central brown); [BEY1 EYCL ]
  • Gene: [00.0/F13A2] coagulation factor XIII, A2 polypeptide;
  • Gene: [00.0/F13A3] coagulation factor XIII, A3 polypeptide;
  • Gene: [00.0/F1L] fibrinogen-like 1 (pT49 protein); [FGL1 HFREP-1 ]
  • Gene: [00.0/F2RL2] coagulation factor II (thrombin) receptor-like 2; proteinase activated receptor 3; [PAR3 ]
  • Gene: [00.0/FAAH] fatty acid amide hydrolase;
  • Gene: [00.0/FAB4] fatty acid binding protein 4, adipocyte; [FABP4 ]
  • Gene: [00.0/FAB5] fatty acid binding protein 5, epidermal (psoriasis-associated); [FABP5 ]
  • Gene: [00.0/FAB7] fatty acid binding protein 7, brain; [FABP7 B-FABP ]
  • Gene: [00.0/FAB9] fatty acid binding protein 9, testis; [FABP9 PERF ]
  • Gene: [00.0/FACL4] fatty-acid-CoA ligase, long-chain 4;
  • Gene: [00.0/FADD] Fas-associating protein with death domain; [MORT1]
  • Gene: [00.0/FANCB] Fanconi anemia, complementation group B gene; Fanconi anemia, complementation group B; Fanconi pancytopenia, type 2; [FAB FA2 ]
  • Gene: [00.0/FANCE] Fanconi anemia, complementation group E gene; Fanconi anemia, complementation group E; Fanconi pancytopenia, type 5; [FACE FAE FA5 ]
  • Gene: [00.0/FANCF] Fanconi anemia, complementation group F gene; Fanconi anemia, complementation group F; [FAF ]
  • Gene: [00.0/FANCG] Fanconi anemia, complementation group G gene; Fanconi anemia, complementation group G; [FAG ]
  • Gene: [00.0/FANCH] Fanconi anemia, complementation group H gene; Fanconi anemia, complementation group H; [FAH ]
  • Gene: [00.0/FBL] fibrillarin;
  • Gene: [00.0/FBP2] fructose-1,6-bisphosphatase 2;
  • Gene: [00.0/FCGBP] Fc fragment of IgG binding protein;
  • Gene: [00.0/FCGR2C] Fc fragment of IgG, low affinity IIc, receptor for (CD32);
  • Gene: [00.0/FDPS] farnesyldiphosphate synthetase (dimethylallyltransferase; EC:2.5.1.1); farnesyldiphosphate synthetase (geranyl-trans-transferase; EC:2.5.1.10);
  • Gene: [00.0/FDX2] ferredoxin 2;
  • Gene: [00.0/FGFR6] fibroblast growth factor receptor 6;
  • Gene: [00.0/FGS2] FG syndrome 2;
  • Gene: [00.0/FHL2] four and a half LIM domains 2; [DRAL SLIM3 ]
  • Gene: [00.0/FHL3] four and a half LIM domains 3; [SLIM2 ]
  • Gene: [00.0/FKBP1L] FK506-binding protein 1-like;
  • Gene: [00.0/FKBP1P1] FK506-binding protein 1 pseudogene 1;
  • Gene: [00.0/FKBP1P2] FK506-binding protein 1 pseudogene 2;
  • Gene: [00.0/FKBP1P3] FK506-binding protein 1 pseudogene 3;
  • Gene: [00.0/FKBP1P4] FK506-binding protein 1 pseudogene 4;
  • Gene: [00.0/FKBP3] FK506-binding protein 3 (25kD);
  • Gene: [00.0/FKBP4] FK506-binding protein 4 (59kD);
  • Gene: [00.0/FKBP5] FK506-binding protein 5 (51kD);
  • Gene: [00.0/FKHL11] forkhead (Drosophila)-like 11;
  • Gene: [00.0/FKHL3] forkhead (Drosophila)-like 3;
  • Gene: [00.0/FKHL6] forkhead (Drosophila)-like 6;
  • Gene: [00.0/FLIP] FLICE-inhibitory protein;
  • Gene: [00.0/FLN1L] filamin 1 (actin-binding protein-280)-like; [TAP TABP ]
  • Gene: [00.0/FMR1L2] fragile X-mental retardation 1-like 2;
  • Gene: [00.0/FOLH2] folate hydrolase 2;
  • Gene: [00.0/FOLHP] folate hydrolase pseudogene;
  • Gene: [00.0/FRAP2] FK506 binding protein 12-rapamycin associated protein 2;
  • Gene: [00.0/FRAT1] frequently rearranged in advanced T-cell lymphomas; proto-oncogene FRAT1;
  • Gene: [00.0/FRDA2] Friedreich ataxia 2;
  • Gene: [00.0/FRK] FYN-related kinase; protein tyrosine kinase FRK;
  • Gene: [00.0/FRP] follistatin-related protein;
  • Gene: [00.0/FSHMD1B] facioscapulohumeral muscular dystrophy 1B;
  • Gene: [00.0/FSP] fibroblast secretory protein;
  • Gene: [00.0/FST] follistatin (activin-binding);
  • Gene: [00.0/FTHP2] ferritin, heavy polypeptide pseudogene 2;
  • Gene: [00.0/FTHP3] ferritin, heavy polypeptide pseudogene 3;
  • Gene: [00.0/FXR2] fragile X mental retardation gene - autosomal homolog 2;
  • Gene: [00.0/FYB] FYN-binding protein (FYB-120/130; SLAP-130); [SLAP130 ]
  • Gene: [00.0/FZD4] frizzled (Drosophila) homolog 4;
  • Gene: [00.0/FZD8] frizzled (Drosophila) homolog 8;
  • Gene: [00.0/G0S2] G0 to G1 switch regulatory 2, 11kD;
  • Gene: [00.0/G6PR] glucose-6-phosphatase, regulatory; [GSD1aSP ]
  • Gene: [00.0/G6PT2] glucose-6-phosphatase, transport (phosphate/pyrophosphate) protein 2; [GSD1c ]
  • Gene: [00.0/G6PT3] glucose-6-phosphatase, transport (glucose) protein 3; [GSD1d ]
  • Gene: [00.0/GAB1] GRB2-associated binding protein 1;
  • Gene: [00.0/GABAT] 4-aminobutyrate aminotransferase, mitochondrial; GABA-transaminase deficiency;
  • Gene: [00.0/GABRP] gamma-aminobutyric acid (GABA) A receptor, pi;
  • Gene: [00.0/GAGE1] G melanoma antigen 1 (directs expression of antigen MZ2-F);
  • Gene: [00.0/GAGE2] G melanoma antigen 2;
  • Gene: [00.0/GAGE3] G melanoma antigen 3;
  • Gene: [00.0/GAGE4] G melanoma antigen 4;
  • Gene: [00.0/GAGE5] G melanoma antigen 5;
  • Gene: [00.0/GAGE6] G melanoma antigen 6;
  • Gene: [00.0/GAJU] gastric juice peptide;
  • Gene: [00.0/GALNT1] UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1);
  • Gene: [00.0/GALNT3] UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3);
  • Gene: [00.0/GATM] glycine amidinotransferase (L-arginine:glycine amidinotransferase);
  • Gene: [00.0/GBP2] guanylate-binding protein 2, interferon-inducible;
  • Gene: [00.0/GBP3] guanylate-binding protein 3, interferon-inducible;
  • Gene: [00.0/GCAG] gastric carcinoma antigen;
  • Gene: [00.0/GCA] grancalcin;
  • Gene: [00.0/GCHFR] GTP cyclohydrolase I feedback regulatory protein; [GFRP ]
  • Gene: [00.0/GCN5L3] GCN5(general control of amino-acid synthesis, yeast, homolog)-like 3;
  • Gene: [00.0/GCN5L4] GCN5(general control of amino-acid synthesis, yeast, homolog)-like 4;
  • Gene: [00.0/GCSH] glycine cleavage system protein H (aminomethyl carrier); hyperglycinemia, isolated nonketotic, type III;
  • Gene: [00.0/GCSL] glycine cleavage system protein L; hyperglycinemia, isolated nonketotic, type IV;
  • Gene: [00.0/GDF1] growth differentiation factor 1;
  • Gene: [00.0/GDF2] growth differentiation factor 2;
  • Gene: [00.0/GDF9] growth differentiation factor 9;
  • Gene: [00.0/GFI2] growth factor independent 2;
  • Gene: [00.0/GFRA3] GDNF family receptor alpha 3;
  • Gene: [00.0/GGT5] gamma-glutamyltransferase 5; gamma-glutamyltransferase-like enzyme activity 1;
  • Gene: [00.0/GHSR] growth hormone secretagogue receptor;
  • Gene: [00.0/GJA2] gap junction protein, alpha 2, 38kD (connexin 38);
  • Gene: [00.0/GJA6] gap junction protein, alpha 6, 45kD (connexin 45);
  • Gene: [00.0/GJB3] gap junction protein, beta 3, 31kD (connexin 31);
  • Gene: [00.0/GLC1F] glaucoma 1, open angle, F (adult-onset);
  • Gene: [00.0/GLC2A] glaucoma 2, angle closure;
  • Gene: [00.0/GLIPR] glioma pathogenesis-related protein; related to testis-specific, vespid, and pathogenesis proteins 1; glioma, type ?; [RTVP1 ]
  • Gene: [00.0/GLUDP4] glutamate dehydrogenase pseudogene 4;
  • Gene: [00.0/GLYD] glycerate-2-dehydrogenase;
  • Gene: [00.0/GMFA] glia maturation factor, alpha; [GMF ]
  • Gene: [00.0/GMFB] glia maturation factor, beta;
  • Gene: [00.0/GML] GPI anchored molecule like protein;
  • Gene: [00.0/GNA12] guanine nucleotide binding protein (G protein), alpha 12;
  • Gene: [00.0/GNA13] guanine nucleotide binding protein (G protein), alpha 13;
  • Gene: [00.0/GNA16] guanine nucleotide binding protein (G protein), alpha 16 (Gq class);
  • Gene: [00.0/GNB5] guanine nucleotide binding protein (G protein), beta polypeptide 5; adenylate cyclase modulator G(I,S,T), beta-5;
  • Gene: [00.0/GNBL1] guanine nucleotide binding protein (G protein), beta polypeptide-like 1 (p205); protein kinase C, receptor of activated, 1 (RACK1); [RACK1 ]
  • Gene: [00.0/GNG10] guanine nucleotide binding protein (G protein), gamma polypeptide 10;
  • Gene: [00.0/GNG3] guanine nucleotide binding protein (G protein), gamma polypeptide 3;
  • Gene: [00.0/GNG4] guanine nucleotide binding protein (G protein), gamma polypeptide 4;
  • Gene: [00.0/GNG5P] guanine nucleotide binding protein (G protein), gamma polypeptide 5 pseudogene;
  • Gene: [00.0/GNG7] guanine nucleotide binding protein (G protein), gamma polypeptide 7;
  • Gene: [00.0/GOLGA1] Golgi autoantigen, golgin subfamily a, 1 (golgin-97);
  • Gene: [00.0/GOLGA2] golgi autoantigen, golgin subfamily a, 2 (golgin-95); [GM130 ]
  • Gene: [00.0/GOLGA3] golgi autoantigen, golgin subfamily a, 3 (golgin-160, golgin-165); [GCP170 ]
  • Gene: [00.0/GP5] glycoprotein V (platelet);
  • Gene: [00.0/GPC2] glypican 2 (cerebroglycan);
  • Gene: [00.0/GPC4] glypican 4;
  • Gene: [00.0/GPR14] G protein-coupled receptor 14;
  • Gene: [00.0/GPR17] G protein-coupled receptor 17;
  • Gene: [00.0/GPR26] G protein-coupled receptor 26;
  • Gene: [00.0/GPR27] G protein-coupled receptor 27;
  • Gene: [00.0/GPR32] G protein-coupled receptor 32;
  • Gene: [00.0/GPR33] G protein-coupled receptor 33;
  • Gene: [00.0/GPR34P] G protein-coupled receptor 34 pseudogene;
  • Gene: [00.0/GPR34] G protein-coupled receptor 34;
  • Gene: [00.0/GPR36] G protein-coupled receptor 36;
  • Gene: [00.0/GPRK7] G protein-coupled receptor kinase 7;
  • Gene: [00.0/GPS1] G protein pathway suppressor 1;
  • Gene: [00.0/GPS2] G protein pathway suppressor 2;
  • Gene: [00.0/GPX5] glutathione peroxidase 5 (epididymal androgen-related protein);
  • Gene: [00.0/GPX6] glutathione peroxidase 6 (olfactory);
  • Gene: [00.0/GPX7] glutathione peroxidase 7;
  • Gene: [00.0/GRB10] growth factor receptor-bound protein 10;
  • Gene: [00.0/GRB7] growth factor receptor-bound protein 7;
  • Gene: [00.0/GRID1] glutamate receptor, ionotropic, delta 1;
  • Gene: [00.0/GRLF1] glucocorticoid receptor DNA binding factor 1;
  • Gene: [00.0/GRM1] glutamate receptor, metabotropic 1;
  • Gene: [00.0/GRM2] glutamate receptor, metabotropic 2;
  • Gene: [00.0/GRM4] glutamate receptor, metabotropic 4;
  • Gene: [00.0/GRM5] glutamate receptor, metabotropic 5;
  • Gene: [00.0/GRM7] glutamate receptor, metabotropic 7;
  • Gene: [00.0/GSK1] glycogen synthase kinase 1;
  • Gene: [00.0/GSK2] glycogen synthase kinase 2;
  • Gene: [00.0/GSK3A] glycogen synthase kinase 3 alpha;
  • Gene: [00.0/GSK3B] glycogen synthase kinase 3 beta;
  • Gene: [00.0/GSTA3] glutathione S-transferase A3;
  • Gene: [00.0/GSTE] glutathione S-transferase E (? class; erythrocyte);
  • Gene: [00.0/GSTMS3] glutathione S-transferase, microsomal, 3;
  • Gene: [00.0/GTF2A1] general transcription factor IIA, polypeptide 1 (37kD and 19kD subunits);
  • Gene: [00.0/GTF2A2] general transcription factor IIA, polypeptide 2 (12kD subunit);
  • Gene: [00.0/GTF2H3] general transcription factor IIH, polypeptide 3 (34kD subunit);
  • Gene: [00.0/GTF3B] general transcription factor IIIB (90kD); [TFIIIB90 hBRF ]
  • Gene: [00.0/GUCY1B2] guanylate cyclase 1, soluble, beta 2;
  • Gene: [00.0/GZMK] granzyme K (serine protease, granzyme 3);
  • Gene: [00.0/H2A5] histone H2A, family 5;
  • Gene: [00.0/H3F3A] H3 histone, family 3A (predominant form in nondividing cells); [H3.3A ]
  • Gene: [00.0/H4F3] H4 histone, family 3;
  • Gene: [00.0/HADHAP] trifunctional protein, mitochondrial, alpha subunit pseudogene; gastrin binding protein pseudogene;
  • Gene: [00.0/HAO] 3-hydroxyanthranilate 3,4-dioxygenase;
  • Gene: [00.0/HAP1] huntingtin-associated protein 1;
  • Gene: [00.0/HAS1] hyaluronan synthase 1;
  • Gene: [00.0/HAS2] hyaluronan synthase 2;
  • Gene: [00.0/HDAC3] histone deacetylase 3; [HD3 ]
  • Gene: [00.0/HE6] G protein-coupled receptor, epididymis-specific;
  • Gene: [00.0/HFL1] complement component H-like protein 1; H factor (complement)-like 1; factor H-related gene 1; complement component H-like protein 2; H factor (complement)-like 2; [H36-1 FHR1 ]
  • Gene: [00.0/HFL4] complement component H-like protein 4; H factor (complement)-like 4, 37.5kD; [DOWN16 ]
  • Gene: [00.0/HHEX] hematopoietically expressed homeobox; homeo box 11-like; [HOX11L ]
  • Gene: [00.0/HK2P] hexokinase 2 pseudogene;
  • Gene: [00.0/HMG17P1] high-mobility group (nonhistone chromosomal) protein 17 pseudogene 1;
  • Gene: [00.0/HMG17P2] high-mobility group (nonhistone chromosomal) protein 17 pseudogene 2;
  • Gene: [00.0/HMG1P] high-mobility group (nonhistone chromosomal) protein 1 pseudogene;
  • Gene: [00.0/HMX3] homeo box (H6 family) 3;
  • Gene: [00.0/HNRPAB] heterogeneous nuclear ribonucleoprotein A/B; RNP particle, heterogeneous nuclear, A/B protein; apolipoprotein B mRNA editing enzyme, catalytic subunit-binding protein 1; [ABBP1 ]
  • Gene: [00.0/HNRPC] heterogeneous nuclear ribonucleoprotein C1/C2 (41kD/43kD); RNP particle, heterogeneous nuclear, C1/C2 protein (41kD/43kD);
  • Gene: [00.0/HNRPL] heterogeneous nuclear ribonucleoprotein L; RNP particle, heterogeneous nuclear, L protein;
  • Gene: [00.0/HNRPU] heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A); RNP particle, heterogeneous nuclear, U protein; [SAFA ]
  • Gene: [00.0/HOKPP2] hypokalemic periodic paralysis 2;
  • Gene: [00.0/HPRT2] hypoxanthine phosphoribosyltransferase 2; hypoxanthine guanine phosphoribosyltransferase 2;
  • Gene: [00.0/HRB] HIV-1 Rev binding protein; hRIP, Rev interacting protein; Rab, Rev/Rex activation domain-binding protein;
  • Gene: [00.0/HRH2] histamine receptor H2;
  • Gene: [00.0/HRPT1] hyperparathyroidism 1;
  • Gene: [00.0/HSD3B3] hydroxy-delta-5-steroid (3 beta-) dehydrogenase 3 (EC:1.1.1.145); giant cell hepatitis, neonatal;
  • Gene: [00.0/HSF2] heat shock transcription factor 2; [HSPF2 HSTF2 ]
  • Gene: [00.0/HSJ1] heat shock protein, neuronal DNAJ-like, 1; [HSPF3 ]
  • Gene: [00.0/HSJ2] heat shock protein, DNAJ-like 2; [HSPF4 ]
  • Gene: [00.0/HSPCA] heat shock 90kD protein 1, alpha; [HSP90A HSP86 ]
  • Gene: [00.0/HSPD1] heat shock 60kD protein 1 (chaperonin);
  • Gene: [00.0/HSPDP1] heat shock 60kD protein 1 (chaperonin) pseudogene 1;
  • Gene: [00.0/HSPDP2] heat shock 60kD protein 1 (chaperonin) pseudogene 2;
  • Gene: [00.0/HSPDP3] heat shock 60kD protein 1 (chaperonin) pseudogene 3;
  • Gene: [00.0/HSPDP4] heat shock 60kD protein 1 (chaperonin) pseudogene 4;
  • Gene: [00.0/HSPDP5] heat shock 60kD protein 1 (chaperonin) pseudogene 5;
  • Gene: [00.0/HSPDP6] heat shock 60kD protein 1 (chaperonin) pseudogene 6;
  • Gene: [00.0/HSPE1] heat shock 10kD protein 1 (chaperonin 10kD);
  • Gene: [00.0/HSPF1] heat shock 40kD protein 1; [Hsp40 ]
  • Gene: [00.0/HSPF2] heat shock 40kD protein 2;
  • Gene: [00.0/HTC1] hypertrichosis universalis (Ambras type);
  • Gene: [00.0/HTX2] heterotaxy 2 (autosomal dominant);
  • Gene: [00.0/HV1S] herpes simplex virus type 1 sensitivity;
  • Gene: [00.0/IBDH] 3-hydroxyisobutyrate dehydrogenase; 3-hydroxyisobutyricaciduria;
  • Gene: [00.0/IBM1] inclusion body myopathy 1, autosomal dominant;
  • Gene: [00.0/ICA2] islet cell autoantigen 2 (ICA12);
  • Gene: [00.0/ICR1] ichthyosis congenita I, erythromatous lamellar ichthyosis; ichthyosiform erythroderma, nonbullous, dominant form; [ADLI ]
  • Gene: [00.0/ICR3] ichthyosis congenita III, vulgaris-like recessive ichthyosis;
  • Gene: [00.0/ICR4] ichthyosis congenita IV, ichthyosis-prematurity syndrome;
  • Gene: [00.0/ICR5] ichthyosis congenita V, Sjogren-Larsson-like;
  • Gene: [00.0/ICSBP1] interferon consensus sequence binding protein 1;
  • Gene: [00.0/ICT1] immature colon carcinoma transcript 1 (digestion subtraction-1); [DS-1 ]
  • Gene: [00.0/IDDM14] insulin-dependent diabetes mellitus 14;
  • Gene: [00.0/IDDM16] insulin-dependent diabetes mellitus 16;
  • Gene: [00.0/IDDM9] insulin-dependent diabetes mellitus 9;
  • Gene: [00.0/IDH3B] isocitrate dehydrogenase 1 (NAD+) beta, mitochondrial;
  • Gene: [00.0/IDI1] isopentenyl diphosphate delta isomerase;
  • Gene: [00.0/IDO] indole 2,3-dioxygenase;
  • Gene: [00.0/IFNI41] interferon-induced protein 41; [IFI41 ]
  • Gene: [00.0/IFNI53] interferon-induced protein 53; [IFI53 ]
  • Gene: [00.0/IFNI75] interferon-induced protein 75; [IFI75 ]
  • Gene: [00.0/IFNP11] interferon pseudogene 11;
  • Gene: [00.0/IFNP12] interferon pseudogene 12;
  • Gene: [00.0/IFNP20] interferon pseudogene 20;
  • Gene: [00.0/IFNP23] interferon pseudogene 23;
  • Gene: [00.0/IFNWP2] interferon, omega pseudogene 2;
  • Gene: [00.0/IFNWP4] interferon, omega pseudogene 4;
  • Gene: [00.0/IFNWP5] interferon, omega pseudogene 5;
  • Gene: [00.0/IGBP1] immunoglobulin (CD79A) binding protein 1;
  • Gene: [00.0/IGFB5] insulin-like growth factor binding protein 5; [IGFBP5 IBP5 ]
  • Gene: [00.0/IGHMR] surface IgM expression factor B34 (IgM Fc-receptor?); [GPB34 ]
  • Gene: [00.0/IGJL] immunoglobulin, J linker, like;
  • Gene: [00.0/IGKV1] immunoglobulin kappa variable region 1;
  • Gene: [00.0/IGKV2] immunoglobulin kappa variable region 2;
  • Gene: [00.0/IGKV3] immunoglobulin kappa variable region 3;
  • Gene: [00.0/IGKVPZ1] immunoglobulin kappa variable region pseudogene Z1;
  • Gene: [00.0/IGKVPZ2] immunoglobulin kappa variable region pseudogene Z2;
  • Gene: [00.0/IGKVPZ3] immunoglobulin kappa variable region pseudogene Z3;
  • Gene: [00.0/IGKVPZ4] immunoglobulin kappa variable region pseudogene Z4;
  • Gene: [00.0/IGSFB29] B-lineage cell surface glycoprotein B29; [GPB29 ]
  • Gene: [00.0/IKBKAP] inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein; [IKAP ]
  • Gene: [00.0/IKBKG] inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; [NEMO ]
  • Gene: [00.0/IL11RB] interleukin 11 receptor, beta;
  • Gene: [00.0/IL14] interleukin 14 (high molecular weight B-cell growth factor);
  • Gene: [00.0/IL15RB] interleukin 15 receptor, beta;
  • Gene: [00.0/IL16] interleukin 16 (lymphocyte chemoattractant factor; LCF); [LCF ]
  • Gene: [00.0/IL18] interleukin 18 (interferon-gamma-inducing factor); [IGIF ]
  • Gene: [00.0/ILF2] interleukin enhancer binding factor 2, 45kD;
  • Gene: [00.0/ILF3L] interleukin enhancer binding factor 3-like;
  • Gene: [00.0/ILF3] interleukin enhancer binding factor 3, 90kD;
  • Gene: [00.0/IMPA2] inositol(myo)-1(or 4)-monophosphatase 2;
  • Gene: [00.0/INCENP] inner centromere protein antigens (135kD, 155kD);
  • Gene: [00.0/ING1] inhibitor of growth 1;
  • Gene: [00.0/INGAP] islet neogenesis associated protein; pancreatic beta cell growth factor;
  • Gene: [00.0/INPP3] inositol polyphosphate-3-phosphatase;
  • Gene: [00.0/INPP4] inositol polyphosphate-4-phosphatase, 106kD;
  • Gene: [00.0/INPP5C] inositol polyphosphate-5-phosphatase, type III, 120kD;
  • Gene: [00.0/INSAF] insulin activator factor (insulin control element-binding transcription factor);
  • Gene: [00.0/IRAK2] interleukin-1 receptor-associated kinase 2;
  • Gene: [00.0/IRF3] interferon regulatory factor 3;
  • Gene: [00.0/IRF6] interferon regulatory factor 6;
  • Gene: [00.0/IRF7] interferon regulatory factor 7;
  • Gene: [00.0/IRLB] c-myc promoter-binding protein;
  • Gene: [00.0/ISG20] interferon stimulated gene (20kD); [HEM45 ]
  • Gene: [00.0/ISGF3G] interferon-induced transcription factor 3, gamma (91/84kD);
  • Gene: [00.0/ITGA3] integrin, alpha 3 (antigen CD49C; alpha 3 subunit of VLA-3 receptor); very late activation protein-3 receptor, alpha-3 subunit (antigen CD49C); [CD49C VLA3R ]
  • Gene: [00.0/ITGA8] integrin, alpha 8;

    •